Market Overview

UPDATE: JP Morgan Downgrades CME Group to Underweight on Falling Volumes

Share:
Related CME
Fast Money Halftime Report Final Trade From January 26
GFI Group Shareholders Should Vote Against Proposed Merger With CME, Says ISS
BGC Partners/GFI Group tennis match continues (Seeking Alpha)

JP Morgan reduced its rating on CME Group (NASDAQ: CME) from Neutral to Underweight and reduced its price target from $56.50 to $54.

JP Morgan said, "We see a disconnect between the fundamentals in CME's core business and the price appreciation and valuation of its stock. While we see the opportunities for both OTC clearing revenue and the migration to listed trading for interest rates, we feel that those opportunities could develop over a longer period of time, leaving investors to focus on the market-condition-driven deterioration in volumes. While a special dividend provides support to the stock, we see the potential for downside with limited upside over the next 6-12 months."

CME Group closed at $59.35 on Thursday.

Latest Ratings for CME

DateFirmActionFromTo
Jan 2015Deutsche BankMaintainsBuy
Jan 2015CitigroupUpgradesNeutralBuy
Jan 2015CLSADowngradesOutperformUnderperform

View More Analyst Ratings for CME
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Downgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (CME)

Around the Web, We're Loving...

Get Benzinga's Newsletters